Click here for slides on this topic


Hyperglycemia

Elevated blood glucose levels. Acute symptoms include frequent urination, increased thirst, and weight loss. If left untreated, hyperglycemia results in chronic diabetes complications: cardiovascular disease, neuropathy, retinopathy, and nephropathy.


The following content matched the glossary term: Hyperglycemia

AACE 2015 guidelines Diabetes & Pregnancy

Top

Summary of recommendations for gestational diabetes mellitus (GDM) from the 2015 AACE guidelines 

AACE 2015 guidelines In-Patient Glycemia Management

Top

Summary of recommendations for managing glycemia for hospitalized patients, including critically ill, from the 2015 AACE diabetes guidelines 

AACE 2015 guidelines Microvascular Complications

Top

Recommendations for managing microvascular complications, including retinopathy, nephropathy, and neuropathy from the 2015 AACE diabetes guidelines 

AACE 2015 guidelines Cardiovascular Disease Management

Top

Summary of recommendations for managing cardiovascular disease (CVD), including dyslipidemia and hypertension, from the 2015 AACE diabetes guidelines 

AACE 2015 guidelines Obesity Management

Top

Summary of the obesity treatment algorithm, including pharmacologic therapy and bariatric surgery, from the 2015 AACE diabetes guidelines 

AACE 2015 guidelines Hypoglycemia Management

Top

Summary of recommendations for managing hypoglycemia from the 2015 AACE diabetes treatment guidelines 

AACE 2015 guidelines Lifestyle Changes

Top

Summary of recommendations for lifestyle modifications to treat diabetes from the 2015 AACE guidelines  

AACE 2015 guidelines Glycemic Control Algorithm

Top

AACE’s glycemic control algorithm outlines pharmacologic treatment options for diabetes from the 2015 AACE guidelines 

AACE 2015 guidelines Glycemic Targets

Top

Summary of glycemic treatment targets, including the A1C goal, from the 2015 AACE diabetes guidelines 

AACE 2015 guidelines Diabetes Diagnosis

Top

Summary of recommendations for screening and diagnosing type 2 diabetes from the 2015 AACE guidelines. 

1 2 3 4 5 6 7 8 9 10  ... Next 

Slide Library Results

Search Results for: Hyperglycemia Slides Found: 77
Meta-Analysis: A1C and CVD in Type 2 Diabetes
Effect of 4 Diets on Weight Loss and Cardiac Risk Factors
Beta-Cell Adaptation to Insulin Resistance: Longitudinal Data in Normal Women
Type 2 Diabetes: Pathogenesis in a Nutshell
Global Impact of Hyperglycemia: Ischemic Heart Disease and Stroke Mortality
Type 2 Diabetes: Pathogenesis in a Nutshell (cont.)
UKPDS: Progressive Deterioration in Glycemic Control Over Time
Early Nutrient-Induced Insulin Secretion
Beta-Cell Mass in Normal Patients and Patients With Diabetes: Autopsy Study
Tools to Assess beta-Cell Health and Function
HEART2D: Primary Outcome Vs Days in Trial by Treatment Strategy
HEART2D Trial: A1C Values at Each Visit for 60 Months
Alogliptin Study 010, Secondary Efficacy Endpoint at Week 26: Hyperglycemia
Alogliptin Study 010: Safety
LOADD: Nutritional Intervention for Persistent, Treated Hyperglycemia
Effect of Liraglutide on Cardiovascular Disease Risk Factors: Design
ACP: Recommendations for Oral Pharmacologic Therapy for Type 2 Diabetes
ACP: Considerations for Oral Pharmacologic Therapy in Type 2 Diabetes
DPP and DPPOS: Timeline
DPP: A Look Back
ADA/AGS 2012 Consensus Report on Diabetes in Older Adults: Key Facts on Prevalence, Epidemiology
ADA/AGS 2012 Consensus Report on Diabetes in Older Adults: Considerations for Individualizing Treatment (2 of 2)
Guidelines for Children and Adolescents With Type 2 Diabetes: Insulin Therapy
Guidelines for Children and Adolescents With Type 2 Diabetes: Blood Glucose Testing (2 of 2)
ACP Guidelines: Inpatient Hyperglycemia Management with IIT
ACP Guidelines: Inpatient Hyperglycemia Management with IIT
Liraglutide Improves ß-Cell Function and Insulin Secretion During Hyperglycemia in Patients With Type 2 Diabetes
IDF Guidelines Type 2 Diabetes Diagnosis Older Adults Elderly | NDEI
IDF Type 2 Diabetes Guidelines In-Patient | NDEI
IDF Type 2 Diabetes Guidelines In-Patient Critically Ill | NDEI
Diabetes Cognitive Dysfunction | NDEI
Diabetes Pregnancy Guidelines Diabetes Testing Endocrine Society | NDEI
Diabetes Pregnancy Guidelines GDM Testing Endocrine Society | NDEI
Diabetes Pregnancy Guidelines Postpartum Care GDM | NDEI
HARMONY 3 Albiglutide A1C Type 2 Diabetes | NDEI
HARMONY 3 Albiglutide FPG Type 2 Diabetes | NDEI
HARMONY 3 Albiglutide DPP-4 Inhibitor Weight Loss Type 2 Diabetes | NDEI
HARMONY 3 Albiglutide DPP-4 Inhibitor Type 2 Diabetes | NDEI
HARMONY 3 Albiglutide Type 2 Diabetes Metformin | NDEI
DPP-4 Inhibitors Type 2 Diabetes Treatment | NDEI
GLP-1 Receptor Agonists Type 2 Diabetes Treatment | NDEI
GLP-1 Receptor Agonists A1C Type 2 Diabetes | NDEI
HARMONY 3 DPP-4 Inhibitors Safety Pancreatitis | NDEI
SGLT2 Dapagliflozin + Insulin Type 1 Diabetes Treatment Slide | NDEI
ACCORD-MIND Hypoglycemia Brain Structure Type 2 Diabetes | NDEI
Phentermine + Topiramate for Weight Loss in Type 2 Diabetes | NDEI PPT
Greater Weight Loss With Phentermine + Topiramate Obesity Type 2 Diabetes | NDEI
Phentermine + Topiramate A1C Targets Obese Subjects With Type 2 Diabetes | NDEI
Phentermine + Topiramate Decreases Need for Antidiabetic Treatments CONQUER | NDEI
Phentermine + Topiramate Safety Obesity Type 2 Diabetes | NDEI PPT
Phentermine Plus Topiramate Weight Loss Obesity Type 2 Diabetes | NDEI
Type 1 Diabetes Classification & Diagnosis
ADA Type 1 Diabetes Guidelines Diagnosis Clues Slide | NDEI
ADA Type 1 Diabetes Guidelines Diagnostic Criteria | NDEI
Inpatient Outpatient Management ADA Type 1 Diabetes Guidelines | NDEI
Child Care Recommendations ADA Type 1 Diabetes Guidelines | NDEI
Inpatient Glycemia Targets ADA Type 1 Diabetes Guidelines | NDEI PPT
ADA EASD Hyperglycemia Management in Type 2 Diabetes PPT | NDEI
ADA EASD Type 2 Diabetes Treatment Hyperglycemia PPT | NDEI
Hyperglycemia Management Type 2 Diabetes ADA EASD PPT | NDEI
ADA EASD Pharmacologic Treatment Diabetes Hyperglycemia | NDEI
Type 2 Diabetes Treatment Options Hyperglycemia ADA EASD | NDEI
ADA EASD Treatment Algorithm Type 2 Diabetes | NDEI
ADA EASD Position Statement Insulin Use in Type 2 Diabetes | NDEI
AACE 2015 Guidelines Criteria for Diagnosing Type 2 Diabetes PPT | NDEI
AACE 2015 Diabetes Guidelines Lifestyle Changes Diet Exercise PPT | NDEI
AACE 2015 Guidelines In-Patient Glycemic Targets Critically Ill A1C | NDEI
AACE 2015 Diabetes Guidelines Treating Hyperglycemia in the Hospital | NDEI
AACE 2015 Diabetes Guidelines Glucose Monitoring in the Hospital In-Patient | NDEI
AACE 2015 Guidelines Treating Gestational Diabetes GDM PPT | NDEI
ADA EASD Position Statement Individualized Glycemic Targets PPT | NDEI
Type 2 Diabetes & CVD Risk AHA ADA Guidelines PPT | NDEI
Criteria for Type 2 Diabetes Diagnosis ADA Guidelines 2016 | NDEI PPT
Metabolic Surgery for Type 2 Diabetes Treatment Guidelines PPT | NDEI
Patient Selection Metabolic Surgery for Type 2 Diabetes Treatment Guidelines | NDEI
Metabolic Surgery Postoperative Follow-Up for Type 2 Diabetes Guidelines | NDEI
Preoperative Workup Metabolic Surgery for Type 2 Diabetes Treatment | NDEI